Concepedia

Publication | Open Access

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience

34

Citations

19

References

2017

Year

Abstract

Low-dose RTX therapy is effective and safe in immunosuppression-resistant IMN.

References

YearCitations

Page 1